(25) measured the frequency of autoreactive CD8+ TSCM cells against GAD65, insulin, and IGRP in new-onset (<6 months T1D) and long-term (>20 years T1D) patients. This evidence concerns the gene GAD2 and type 1 diabetes mellitus.